Data Horizon Co., Ltd. (3628) AI Stock Analysis

Compare

0 Followers

Top Page

Data Horizon Co., Ltd.

(3628)

Rating:42Neutral

Price Target:

¥467.00

▲( 3.55% Upside)

The overall stock score is primarily driven by significant financial performance challenges, including declining revenue and cash flow issues. Technical analysis indicates neutral conditions, while valuation is unfavorable due to a negative P/E ratio. The absence of earnings call insights and corporate events further limits positive assessment.

Data Horizon Co., Ltd. (3628) vs. iShares MSCI Japan ETF (EWJ)

Market Cap

¥5.70B

Dividend YieldN/A

Average Volume (3M)25.30K

Price to Earnings (P/E)―

Beta (1Y)0.67

Revenue Growth-9.71%

EPS Growth-484.01%

CountryJP

Employees374

SectorHealthcare

Sector Strength40

IndustryMedical - Healthcare Information Services

Share Statistics

EPS (TTM)-188.55

Shares Outstanding12,711,780

10 Day Avg. Volume47,930

30 Day Avg. Volume25,303

Financial Highlights & Ratios

PEG Ratio0.91

Price to Book (P/B)2.14

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Data Horizon Co., Ltd. Business Overview & Revenue Model

Company DescriptionData Horizon Co., Ltd. (3628) is a technology company that specializes in providing data management and analysis solutions. The company operates primarily in the sectors of healthcare and information technology, offering services that include electronic medical records management, medical data analysis, and health information systems. Data Horizon aims to enhance the efficiency and quality of healthcare delivery through its innovative data solutions.

How the Company Makes MoneyData Horizon Co., Ltd. generates revenue through a combination of service contracts, subscription fees, and consulting services. Its primary revenue streams include the sale and maintenance of its electronic medical records systems, which are used by healthcare providers to manage patient information efficiently. Additionally, the company offers data analysis services that provide actionable insights to healthcare organizations, enabling them to improve patient care and operational efficiency. Significant partnerships with healthcare institutions and technology firms also contribute to the company's earnings, allowing it to broaden its market reach and enhance its service offerings.

Data Horizon Co., Ltd. Financial Statement Overview

Summary

Data Horizon Co., Ltd. faces significant financial challenges, characterized by declining revenues, negative profitability margins, and increasing leverage. The weak cash flow generation further exacerbates these issues, highlighting liquidity risks. The company needs strategic measures to enhance revenue growth and improve operational efficiency to stabilize its financial position.

Income Statement

Negative

The company exhibits a significant decline in revenue and profitability, with negative EBIT and net income margins for both TTM and annual data. Revenue growth has been inconsistent, and recent periods show a contraction in sales. The gross profit margin remains relatively high but is undermined by substantial operating losses.

Balance Sheet

Neutral

The balance sheet shows high leverage with a rising debt-to-equity ratio, indicating increased financial risk. Stockholders' equity has been declining, further affecting the equity ratio negatively. While total assets have grown, the increase in liabilities poses a challenge to financial stability.

Cash Flow

Negative

Cash flow statements reveal negative free cash flow in recent periods, with operating cash flow unable to cover capital expenditures. The company's cash generation ability is weak, with no positive free cash flow growth observed. This raises concerns about liquidity and the ability to sustain operations without external financing.

TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Breakdown
Income Statement		Total Revenue
4.82B	5.01B	4.41B	2.99B	3.33B	2.78B
	Gross Profit
1.09B	1.49B	1.42B	1.26B	1.78B	1.45B
	EBIT
-973.52M	-789.85M	-498.50M	-315.91M	348.75M	262.96M
	EBITDA
-250.63M	-148.66M	-222.73M	-246.87M	478.03M	395.04M
	Net Income Common Stockholders
-959.54M	-807.18M	-664.86M	-410.80M	283.92M	201.76M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
929.28M	1.42B	1.08B	379.98M	1.06B	1.12B
	Total Assets
8.76B	6.66B	6.39B	2.26B	2.28B	1.99B
	Total Debt
4.24B	2.46B	1.47B	400.00M	2.66M	16.02M
	Net Debt
3.31B	1.04B	391.61M	20.02M	-1.06B	-1.10B
	Total Liabilities
5.23B	3.44B	2.36B	977.21M	709.94M	687.49M
	Stockholders Equity
3.50B	3.19B	3.97B	1.26B	1.54B	1.28B
Cash Flow		Free Cash Flow
0.00	-678.92M	-923.59M	-1.04B	68.16M	402.95M
	Operating Cash Flow
0.00	120.13M	-198.37M	-442.98M	395.94M	532.86M
	Investing Cash Flow
0.00	-789.14M	-3.51B	-572.80M	-391.51M	-80.47M
	Financing Cash Flow
0.00	1.02B	4.41B	331.20M	-56.21M	-41.58M

Data Horizon Co., Ltd. Technical Analysis

Technical Analysis Sentiment

Neutral

Last Price451.00

Price Trends

50DMA

446.88

Positive

100DMA

474.78

Negative

200DMA

467.62

Negative

Market Momentum

MACD

5.02

Negative

RSI

52.06

Neutral

STOCH

32.39

Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3628, the sentiment is Neutral. The current price of 451 is above the 20-day moving average (MA) of 438.60, above the 50-day MA of 446.88, and below the 200-day MA of 467.62, indicating a neutral trend. The MACD of 5.02 indicates Negative momentum. The RSI at 52.06 is Neutral, neither overbought nor oversold. The STOCH value of 32.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3628.

Data Horizon Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (53)

Financial Indicators

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3671	82 Outperform	¥5.35B	8.28		3.36%	16.07%	72.83%
4172	76 Outperform	¥4.81B	11.64		4.72%	23.59%	122.48%
6095	74 Outperform	¥15.54B	8.97		0.64%	-12.13%	291.07%
Sector *	53 Neutral	$5.15B	3.03	-44.53%	2.84%	16.85%	-0.12%
4263	45 Neutral	¥9.57B	―		―	-79.38%	-1239.83%
3902	43 Neutral	¥14.97B	4,465.71		1.69%	-7.98%	-181.00%
3628	42 Neutral	¥5.70B	―		―	-9.71%	-484.01%

* Healthcare Sector Average

Performance Comparison

JP:3628

Data Horizon Co., Ltd.

451.00

-118.00

-20.74%

JP:3671

Softmax Co., Ltd. (Japan)

895.00

136.77

18.04%

JP:3902

Medical Data Vision Co.Ltd.

390.00

-75.87

-16.29%

JP:4172

TOWA Hi SYSTEM Co., Ltd.

2,160.00

568.00

35.68%

JP:4263

SUSMED,Inc.

576.00

44.00

8.27%

JP:6095

MedPeer, Inc.

719.00

142.44

24.71%

Glossary

OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.

NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.

UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.